FDA Approves Jemperli for Certain Locally Advanced Rectal Cancer
GSK said the FDA approved Jemperli as the first and only immunotherapy for adults with stage II and III MSI-H/dMMR locally advanced rectal cancer.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.